Price movement over the last 24 hours
Arwana Citramulia Tbk vs Merck Tbk. — how do they compare? Arwana Citramulia Tbk trades at Rp462 (market cap 3.32T, 814.1K 24h volume), while Merck Tbk. trades at Rp3,730 (market cap 1.65T, 60.4K 24h volume). The key difference: Arwana Citramulia Tbk is far larger — about 2× Merck Tbk.'s market cap, and Arwana Citramulia Tbk is more actively traded (814.1K versus 60.4K). Which is the better fit depends on your goals.
| ARNA | MERK | |
|---|---|---|
Market Cap | 3.32T | 1.65T |
Volume | 814.1K | 60.4K |
Lot | 8.14K | 604 |
Turnover | 368.09M | 223.42M |
Average Price | 452.14 | 3,698.92 |
Value | 368.09M | 223.42M |
Indicative Equilibrium Price | 462 | — |
Indicative Equilibrium Volume | 261 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Arwana Citramulia Tbk (the Company) was established under the name PT Arwana Citra Mulia based on the notarial deed No. 21 dated February 22, 1993 of Raden Santoso, as amended by notarial deeds No. 147 dated October 26, 1993 and No. 105 dated November 15, 1993 of Imam Santoso, S.H., which covered, among others, the change in the Company's name PT Arwana Citramulia.
Read more on ARNA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →